Stocks of the Hour: Terrain Minerals, Leeuwin Metals, LTR Pharma

Informed Investor08-13


Terrain Minerals (ASX:TMX) has announced that high-priority nickel-copper targets identified in Lort River Project's "Eye" feature. The Airborne electromagnetic (AEM) survey reveals five potential mineral-rich zones within the project. Shares are trading flat at 0.35 cents.

Leeuwin Metals (ASX:LM1) has announced highly encouraging iron ore rock chips from first pass exploration at the West Pilbara Project, Western Australia. The large scale mineralisation is evident over 1.7km of strike and remains open. Shares are trading 16.44 per cent higher at 8.5 cents.

LTR Pharma (ASX:LTP) and Aptar Pharma have entered into a Co-Development Agreement for SPONTAN® for global markets. SPONTAN® is LTR Pharma’s lead product used to treat Erectile Dysfunction in 10 minutes or less. The Agreement will combine LTR’s pharmaceutical development capabilities with Aptar Pharma’s expertise in nasal spray technology, supporting a streamlined regulatory pathway and market access for SPONTAN. Shares are trading 22.28 per cent higher at $1.18.  
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment